Odonate Therapeutics (ODT) News Today → AI Cracks Open Largest Untapped Energy Reserve on Earth (From Banyan Hill Publishing) (Ad) Free ODT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineProQR Therapeutics NV (PRQR)investing.com - February 6 at 5:38 PMOrally Disintegrating Tablet (ODT) Market 2023 | Future Exploration by 2030marketwatch.com - March 29 at 5:49 PMPfizer recalls migraine drug Nurtec ODT after millions of products lacked child resistant packagingusatoday.com - March 19 at 2:17 AMFate Therapeutics Stock (NASDAQ:FATE), Analyst Ratings, Price Targets, Predictionsbenzinga.com - March 3 at 9:05 PMOrally Disintegrating Tablet (ODT) Market Size 2023 with Big Company Segment, Cost-Effective Solutions Analysis Information 2029marketwatch.com - January 31 at 12:32 AMODTC Odonate Therapeutics, Inc.seekingalpha.com - October 22 at 9:26 PMOdonate Therapeuticsforbes.com - September 14 at 9:58 PMODONATE INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Odonate Therapeutics, Inc. - ODTfinance.yahoo.com - December 10 at 11:49 PMOdonate Therapeutics Insider Sold Over $2.5M In Company Stockfinance.yahoo.com - November 22 at 2:43 PMOdonate Therapeutics, Inc. (ODT)uk.finance.yahoo.com - October 27 at 2:27 AMOne Odonate Therapeutics, Inc. (NASDAQ:ODT) insider upped their stake in the previous yearnasdaq.com - September 27 at 1:37 PMSHAREHOLDER ALERT: Morris Kandinov Investigating ODT, AYTU, EAR, and CORT; Shareholders are Encouraged to Contact the Firmfinance.yahoo.com - September 8 at 7:55 AMA Odonate Therapeutics, Inc. (NASDAQ:ODT) insider increased their holdings last yearfinance.yahoo.com - September 6 at 4:05 PMOdonate Therapeutics Inc.barrons.com - August 26 at 9:57 PMODONATE INVESTIGATION INITIATED by Former...benzinga.com - August 21 at 6:42 AMUpdate in Lawsuit for Investors in Odonate Therapeutics, Inc. (NASDAQ:ODT) Announced by Shareholders Foundationfinance.yahoo.com - August 17 at 7:30 AMKaskela Law LLC Announces Stockholder Investigation of Odonate Therapeutics, Inc. - ODTfinance.yahoo.com - August 16 at 4:07 PMSHAREHOLDER ALERT: Odonate Therapeutics, Inc. (ODT) Officers and Directors Under Investigation for Possible False Statements to Investorsfinance.yahoo.com - August 13 at 4:28 PMNASDAQ: ODT Investor Notice: Update in Lawsuit against Odonate Therapeutics, Inc. announced by Shareholders Foundationbenzinga.com - August 10 at 7:23 AMThe Law Offices of Frank R. Cruz Announces Investigation of Odonate Therapeutics, Inc. (ODT) on Behalf of Investorsfinance.yahoo.com - August 7 at 12:00 AMOdonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021finance.yahoo.com - July 27 at 9:19 AM Get Odonate Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ODT and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent new message from Porter Stansberry (Ad)I’ve been in the financial markets for close to three decades… Yet, I’ve never seen an opportunity that’s so urgent, so critical, and yet so overlooked than what is unfolding right now. You see, in one corner of the markets a financial anomaly has emerged that promises to be the single most important story of 2024. Click here now to get what could be the most urgent, and most lucrative research, my team has ever r ODT Media Mentions By Week ODT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ODT News Sentiment▼0.000.62▲Average Medical News Sentiment ODT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ODT Articles This Week▼00▲ODT Articles Average Week Get Odonate Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ODT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ADC Therapeutics News LAVA Therapeutics News Mainz Biomed News NLS Pharmaceutics News Pharvaris News Procaps Group News Qilian International Holding Group News Aclarion News Alpha Tau Medical News Alvotech News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ODT) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetrySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Odonate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.